Brain and central nervous system tumors Trials in Lausanne, Switzerland
Conditions / Brain and central nervous system tumors / Lausanne, Switzerland
Brain and central nervous system tumors has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00019422 | Lobradimil and Carboplatin in Treating Children With Brain Tumors | COMPLETED | PHASE2 |
| NCT00002840 | Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | COMPLETED | PHASE3 |
| NCT00182819 | Radiation Therapy or Temozolomide in Treating Patients With Gliomas | COMPLETED | PHASE3 |
| NCT00014300 | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme | COMPLETED | PHASE2 |
| NCT00003731 | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors | COMPLETED | PHASE2 |
| NCT00002620 | Radiation Therapy in Treating Patients With Brain Cancer | COMPLETED | PHASE3 |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | COMPLETED | PHASE2 |
| NCT00028795 | Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma | COMPLETED | PHASE2 |
| NCT00039364 | Imatinib Mesylate in Treating Patients With Gliomas | COMPLETED | PHASE2 |
| NCT00006102 | Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 |